Ultragenyx Pharmaceutical OverviewUltragenyx Pharmaceutical Other Income Expense Net
Other Income/Expense Net for RARE.
Quarterly Other Income/Expense
-$15.00M
↓ 119.59% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$43.77M
↓ 30.4% YoY
Trailing 12 months ending Mar 31, 2026